British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease
OftalmologiaResumo original em inglês
O que aconteceu
Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition-conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams.
Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.
O estudo original
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease
Elizabeth J Price, Stuart Benjamin, Michele Bombardieri, Simon Bowman, Sara Carty, Coziana Ciurtin, Bridget Crampton, Annabel Dawson, Benjamin A Fisher, Ian Giles et al.
Descritores MeSH
- Sjogren's Syndrome
- Rheumatology
- Child
- United Kingdom
- Humans
- Quality of Life
- Societies, Medical
- Age of Onset
- Adolescent
- Disease Management
Veja também
Estudos relacionados
- The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus
- The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis
- A diretriz da Sociedade Britânica de Reumatologia 2026 para o tratamento da polimialgia reumática
- The 2026 British Society for Rheumatology guideline for pain management in people with inflammatory arthritis